Splenectomy for massive splenomegaly
- 1 April 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 76 (4) , 395-397
- https://doi.org/10.1002/bjs.1800760426
Abstract
Twenty-four patients who underwent resection of giant spleen (spleen weight > 1·5 kg) have been reviewed to determine the difficulties and benefits of the procedure and, in particular, whether the use of adrenaline injection into the splenic artery could safely reduce technical difficulty. Although morbidity was higher in patients with giant spleens compared with those undergoing resection of smaller spleens the incidence of serious complications was small, and there were no operative or in-hospital deaths. In addition, virtually all patients benefited either on the basis of minimized haematological defect, or palliation of symtoms. Further, the injection of 1 ml of 1:10000 adrenaline into the splenic artery before splenic mobilization reduced the splenic volume by approximately 40 per cent on average, and resulted in improved exposure, thereby facilitating the procedure.Keywords
Funding Information
- Kabi Vitrum Laboratories, Stockholm, Sweden
This publication has 7 references indexed in Scilit:
- Metabolism in hematologic malignancyCancer, 1988
- Splenectomy as primary treatment for hairy cell leukaemiaBritish Journal of Surgery, 1987
- Splenectomy for massive splenomegalyBritish Journal of Surgery, 1987
- Splenectomy for malignant lymphomasWorld Journal of Surgery, 1985
- Removal of the massive spleen: A surgical risk?The American Journal of Surgery, 1984
- Splenectomy: Indications, hazards and alternativesBritish Journal of Surgery, 1984
- Splenectomy for massive splenomegalyThe American Journal of Surgery, 1978